JN Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Neurophysiol 85: 280-286, 2001;
0022-3077/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (41)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heinricher, M. M.
Right arrow Articles by Tortorici, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heinricher, M. M.
Right arrow Articles by Tortorici, V.

The Journal of Neurophysiology Vol. 85 No. 1 January 2001, pp. 280-286
Copyright ©2001 by the American Physiological Society

Circuitry Underlying Antiopioid Actions of Cholecystokinin Within the Rostral Ventromedial Medulla

M. M. Heinricher, S. McGaraughty, and V. Tortorici

Department of Neurological Surgery, Oregon Health Sciences University, Portland, Oregon 97201

Heinricher, M. M., S. McGaraughty, and V. Tortorici. Circuitry Underlying Antiopioid Actions of Cholecystokinin Within the Rostral Ventromedial Medulla. J. Neurophysiol. 85: 280-286, 2001. It is now well established that the analgesic actions of opioids can be modified by "anti-analgesic" or "antiopioid" peptides, among them cholecystokinin (CCK). Although the focus of much recent work concerned with CCK-opioid interactions has been at the level of the spinal cord, CCK also acts within the brain to modify opioid analgesia. The aim of the present study was to characterize the actions of CCK in a brain region in which the circuitry mediating the analgesic actions of opioids is relatively well understood, the rostral ventromedial medulla (RVM). Single-cell recording was combined with local infusion of CCK in the RVM and systemic administration of morphine in lightly anesthetized rats. The tail-flick reflex was used as a behavioral index of nociceptive responsiveness. Two classes of RVM neurons with distinct responses to opioids have been identified. OFF cells are activated, indirectly, by morphine and µ-opioid agonists, and there is strong evidence that this activation is crucial to opioid antinociception. ON cells, thought to facilitate nociception, are directly inhibited by opioids. Cells of a third class, NEUTRAL cells, do not respond to opioids, and whether they have any role in nociceptive modulation is unknown. CCK microinjected into the RVM by itself had no effect on tail flick latency or the firing of any cell class but significantly attenuated opioid activation of OFF cells and inhibition of the tail flick. Opioid suppression of ON-cell firing was not significantly altered by CCK. Thus CCK acting within the RVM attenuates the analgesic effect of systemically administered morphine by preventing activation of the putative pain inhibiting output neurons of the RVM, the OFF cells. CCK thus differs from another antiopioid peptide, orphanin FQ/nociceptin, which interferes with opioid analgesia by potently suppressing all OFF-cell firing.




This article has been cited by other articles:


Home page
 BrainHome page
W. Zhang, S. Gardell, D. Zhang, J. Y. Xie, R. S. Agnes, H. Badghisi, V. J. Hruby, N. Rance, M. H. Ossipov, T. W. Vanderah, et al.
Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptors
Brain, March 1, 2009; 132(3): 778 - 787.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. P. Davis and M. Angst
In Reply
J. Clin. Oncol., March 20, 2008; 26(9): 1565 - 1565.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
J. Streltzer and L. Johansen
Prescription Drug Dependence and Evolving Beliefs About Chronic Pain Management
Am J Psychiatry, April 1, 2006; 163(4): 594 - 598.
[Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
W. Kincaid, M. J. Neubert, M. Xu, C. J. Kim, and M. M. Heinricher
Role for Medullary Pain Facilitating Neurons in Secondary Thermal Hyperalgesia
J Neurophysiol, January 1, 2006; 95(1): 33 - 41.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
I. D. Meng, J. P. Johansen, I. Harasawa, and H. L. Fields
Kappa Opioids Inhibit Physiologically Identified Medullary Pain Modulating Neurons and Reduce Morphine Antinociception
J Neurophysiol, March 1, 2005; 93(3): 1138 - 1144.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Mollereau, H. Mazarguil, J.-M. Zajac, and M. Roumy
Neuropeptide FF (NPFF) Analogs Functionally Antagonize Opioid Activities in NPFF2 Receptor-Transfected SH-SY5Y Neuroblastoma Cells
Mol. Pharmacol., March 1, 2005; 67(3): 965 - 975.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Y. Xie, D. S. Herman, C.-O. Stiller, L. R. Gardell, M. H. Ossipov, J. Lai, F. Porreca, and T. W. Vanderah
Cholecystokinin in the Rostral Ventromedial Medulla Mediates Opioid-Induced Hyperalgesia and Antinociceptive Tolerance
J. Neurosci., January 12, 2005; 25(2): 409 - 416.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
M. M. Heinricher and M. J. Neubert
Neural Basis for the Hyperalgesic Action of Cholecystokinin in the Rostral Ventromedial Medulla
J Neurophysiol, October 1, 2004; 92(4): 1982 - 1989.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. S. Mogil and G. W. Pasternak
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Pharmacol. Rev., September 1, 2001; 53(3): 381 - 415.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online